Martin S. Tallman, MD

Chief, Leukemia Service
Pictured: Martin S. Tallman

Chief of the Leukemia Service Martin S. Tallman discusses how Memorial Sloan Kettering’s experts collaborate to deliver the most-promising therapies, and how he cares for patients as if they were members of his own family.


I am a board-certified hematologist and oncologist and Chief of the Leukemia Service at Memorial Sloan Kettering Cancer Center.

Memorial Sloan Kettering has a very distinguished history in the development of cutting-edge effective therapies for a wide variety of leukemias. Physicians at Memorial Sloan Kettering were among the first to develop effective therapies for patients with acute lymphoblastic leukemia, acute myeloid leukemia, and acute promyelocytic leukemia.

My clinical expertise is in treating patients with acute myeloid leukemia and acute lymphoblastic leukemia, but I also see patients with the chronic leukemias and myelodysplastic syndromes. My patient-care philosophy is to always imagine every patient as a member of my own family. With this in mind, I know I am going to make the best decisions I can for each patient.

Appointments for New Patients
Clinical Expertise

Acute and Chronic Leukemias; Myelodysplastic Syndromes; Myeloproliferative Neoplasms; Stem Cell Transplantation; Hairy cell Leukemia; Development of New Therapies

Languages Spoken
English; French

MD, Chicago Medical School


Evanston Hospital/Northwestern University


Fred Hutchinson Cancer Research Center/University of Washington

Board Certifications

Internal Medicine; Medical Oncology; Hematology

Publications by Martin S. Tallman
Visit PubMed for full listing of Martin S. Tallman journal articles
Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.